145.6 USD
-5.35 (-3.54%)
Overall HLNE gets a fundamental rating of 7 out of 10. We evaluated HLNE against 235 industry peers in the Capital Markets industry. HLNE has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. HLNE shows excellent growth, but is valued quite expensive already. These ratings could make HLNE a good candidate for growth and quality investing.
1. Profitability
1.1 Basic Checks
HLNE had positive earnings in the past year.
In the past year HLNE had a positive cash flow from operations.
Each year in the past 5 years HLNE has been profitable.
Each year in the past 5 years HLNE had a positive operating cash flow.
1.2 Ratios
The Return On Assets of HLNE (11.52%) is better than 91.91% of its industry peers.
With an excellent Return On Equity value of 27.63%, HLNE belongs to the best of the industry, outperforming 93.19% of the companies in the same industry.
With an excellent Return On Invested Capital value of 17.26%, HLNE belongs to the best of the industry, outperforming 92.77% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for HLNE is significantly above the industry average of 7.17%.
The 3 year average ROIC (22.58%) for HLNE is well above the current ROIC(17.26%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.52% | ||
| ROE | 27.63% | ||
| ROIC | 17.26% |
ROA(3y)11.28%
ROA(5y)10.68%
ROE(3y)28.1%
ROE(5y)33.18%
ROIC(3y)22.58%
ROIC(5y)19.69%
1.3 Margins
HLNE has a better Profit Margin (31.12%) than 78.30% of its industry peers.
HLNE's Profit Margin has improved in the last couple of years.
HLNE's Operating Margin of 43.20% is fine compared to the rest of the industry. HLNE outperforms 78.30% of its industry peers.
In the last couple of years the Operating Margin of HLNE has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 43.2% | ||
| PM (TTM) | 31.12% | ||
| GM | N/A |
OM growth 3Y-1.19%
OM growth 5Y0.87%
PM growth 3Y-8.59%
PM growth 5Y6.57%
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
Compared to 1 year ago, HLNE has more shares outstanding
HLNE has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, HLNE has a worse debt to assets ratio.
2.2 Solvency
HLNE has an Altman-Z score of 5.69. This indicates that HLNE is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 5.69, HLNE belongs to the top of the industry, outperforming 88.09% of the companies in the same industry.
The Debt to FCF ratio of HLNE is 0.84, which is an excellent value as it means it would take HLNE, only 0.84 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 0.84, HLNE belongs to the best of the industry, outperforming 88.94% of the companies in the same industry.
HLNE has a Debt/Equity ratio of 0.35. This is a healthy value indicating a solid balance between debt and equity.
HLNE has a Debt to Equity ratio of 0.35. This is in the better half of the industry: HLNE outperforms 71.49% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.35 | ||
| Debt/FCF | 0.84 | ||
| Altman-Z | 5.69 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
A Current Ratio of 1.14 indicates that HLNE should not have too much problems paying its short term obligations.
The Current ratio of HLNE (1.14) is comparable to the rest of the industry.
A Quick Ratio of 1.14 indicates that HLNE should not have too much problems paying its short term obligations.
HLNE has a Quick ratio (1.14) which is comparable to the rest of the industry.
HLNE does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.14 | ||
| Quick Ratio | 1.14 |
3. Growth
3.1 Past
HLNE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 13.70%, which is quite good.
The Earnings Per Share has been growing by 20.18% on average over the past years. This is a very strong growth
HLNE shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.01%.
Measured over the past years, HLNE shows a very strong growth in Revenue. The Revenue has been growing by 21.08% on average per year.
EPS 1Y (TTM)13.7%
EPS 3Y4.79%
EPS 5Y20.18%
EPS Q2Q%43.93%
Revenue 1Y (TTM)13.01%
Revenue growth 3Y24.67%
Revenue growth 5Y21.08%
Sales Q2Q%27.25%
3.2 Future
The Earnings Per Share is expected to grow by 16.02% on average over the next years. This is quite good.
The Revenue is expected to grow by 17.12% on average over the next years. This is quite good.
EPS Next Y11.06%
EPS Next 2Y12.54%
EPS Next 3Y16.02%
EPS Next 5YN/A
Revenue Next Year10.86%
Revenue Next 2Y15.44%
Revenue Next 3Y17.12%
Revenue Next 5YN/A
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 27.42, HLNE can be considered very expensive at the moment.
Based on the Price/Earnings ratio, HLNE is valued a bit more expensive than 67.23% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.25. HLNE is around the same levels.
With a Price/Forward Earnings ratio of 22.81, HLNE is valued on the expensive side.
Based on the Price/Forward Earnings ratio, HLNE is valued a bit more expensive than 61.28% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.98. HLNE is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 27.42 | ||
| Fwd PE | 22.81 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, HLNE is valued a bit cheaper than the industry average as 68.09% of the companies are valued more expensively.
HLNE's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 23.89 | ||
| EV/EBITDA | 25.68 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates HLNE does not grow enough to justify the current Price/Earnings ratio.
HLNE has an outstanding profitability rating, which may justify a higher PE ratio.
HLNE's earnings are expected to grow with 16.02% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.48
PEG (5Y)1.36
EPS Next 2Y12.54%
EPS Next 3Y16.02%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 1.47%, HLNE has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 6.19, HLNE is paying slightly less dividend.
Compared to the average S&P500 Dividend Yield of 1.92, HLNE is paying slightly less dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.47% |
5.2 History
The dividend of HLNE is nicely growing with an annual growth rate of 19.56%!
HLNE has been paying a dividend for over 5 years, so it has already some track record.
HLNE has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)19.56%
Div Incr Years7
Div Non Decr Years7
5.3 Sustainability
HLNE pays out 35.76% of its income as dividend. This is a sustainable payout ratio.
The dividend of HLNE is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP35.76%
EPS Next 2Y12.54%
EPS Next 3Y16.02%
NASDAQ:HLNE (1/13/2026, 11:50:23 AM)
145.6
-5.35 (-3.54%)
Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)
Earnings (Next)
Inst Owners97.93%
Inst Owner Change0.4%
Ins Owners7.22%
Ins Owner Change-2.84%
Market Cap8.12B
Revenue(TTM)733.07M
Net Income(TTM)228.13M
Analysts80
Price Target167.57 (15.09%)
Short Float %5.96%
Short Ratio4.49
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.47% |
Yearly Dividend1.38
Dividend Growth(5Y)19.56%
DP35.76%
Div Incr Years7
Div Non Decr Years7
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)32.23%
Min EPS beat(2)27.41%
Max EPS beat(2)37.05%
EPS beat(4)4
Avg EPS beat(4)19.28%
Min EPS beat(4)1.1%
Max EPS beat(4)37.05%
EPS beat(8)6
Avg EPS beat(8)14.71%
EPS beat(12)8
Avg EPS beat(12)7.46%
EPS beat(16)12
Avg EPS beat(16)13.67%
Revenue beat(2)2
Avg Revenue beat(2)3.09%
Min Revenue beat(2)1.01%
Max Revenue beat(2)5.16%
Revenue beat(4)4
Avg Revenue beat(4)6.08%
Min Revenue beat(4)1.01%
Max Revenue beat(4)13.69%
Revenue beat(8)6
Avg Revenue beat(8)8.54%
Revenue beat(12)7
Avg Revenue beat(12)5.4%
Revenue beat(16)9
Avg Revenue beat(16)8.16%
PT rev (1m)-0.52%
PT rev (3m)-0.67%
EPS NQ rev (1m)0.07%
EPS NQ rev (3m)10.47%
EPS NY rev (1m)0.69%
EPS NY rev (3m)11.61%
Revenue NQ rev (1m)0.02%
Revenue NQ rev (3m)7.29%
Revenue NY rev (1m)0.08%
Revenue NY rev (3m)3.16%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 27.42 | ||
| Fwd PE | 22.81 | ||
| P/S | 11.08 | ||
| P/FCF | 23.89 | ||
| P/OCF | 23.1 | ||
| P/B | 9.84 | ||
| P/tB | 9.84 | ||
| EV/EBITDA | 25.68 |
EPS(TTM)5.31
EY3.65%
EPS(NY)6.38
Fwd EY4.38%
FCF(TTM)6.1
FCFY4.19%
OCF(TTM)6.3
OCFY4.33%
SpS13.14
BVpS14.8
TBVpS14.8
PEG (NY)2.48
PEG (5Y)1.36
Graham Number42.05
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.52% | ||
| ROE | 27.63% | ||
| ROCE | 20.63% | ||
| ROIC | 17.26% | ||
| ROICexc | 21.92% | ||
| ROICexgc | 22.44% | ||
| OM | 43.2% | ||
| PM (TTM) | 31.12% | ||
| GM | N/A | ||
| FCFM | 46.4% |
ROA(3y)11.28%
ROA(5y)10.68%
ROE(3y)28.1%
ROE(5y)33.18%
ROIC(3y)22.58%
ROIC(5y)19.69%
ROICexc(3y)26.87%
ROICexc(5y)22.9%
ROICexgc(3y)28.19%
ROICexgc(5y)23.88%
ROCE(3y)26.99%
ROCE(5y)23.55%
ROICexgc growth 3Y19.01%
ROICexgc growth 5Y-5.25%
ROICexc growth 3Y19.07%
ROICexc growth 5Y-4.68%
OM growth 3Y-1.19%
OM growth 5Y0.87%
PM growth 3Y-8.59%
PM growth 5Y6.57%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.37
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.35 | ||
| Debt/FCF | 0.84 | ||
| Debt/EBITDA | 0.88 | ||
| Cap/Depr | 119.21% | ||
| Cap/Sales | 1.57% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 107.75% | ||
| Profit Quality | 149.1% | ||
| Current Ratio | 1.14 | ||
| Quick Ratio | 1.14 | ||
| Altman-Z | 5.69 |
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)109.9%
Cap/Depr(5y)192.46%
Cap/Sales(3y)1.53%
Cap/Sales(5y)2.53%
Profit Quality(3y)135.75%
Profit Quality(5y)139.47%
High Growth Momentum
Growth
EPS 1Y (TTM)13.7%
EPS 3Y4.79%
EPS 5Y20.18%
EPS Q2Q%43.93%
EPS Next Y11.06%
EPS Next 2Y12.54%
EPS Next 3Y16.02%
EPS Next 5YN/A
Revenue 1Y (TTM)13.01%
Revenue growth 3Y24.67%
Revenue growth 5Y21.08%
Sales Q2Q%27.25%
Revenue Next Year10.86%
Revenue Next 2Y15.44%
Revenue Next 3Y17.12%
Revenue Next 5YN/A
EBIT growth 1Y8.36%
EBIT growth 3Y23.2%
EBIT growth 5Y22.13%
EBIT Next Year15.81%
EBIT Next 3Y14%
EBIT Next 5YN/A
FCF growth 1Y71.96%
FCF growth 3Y21.48%
FCF growth 5Y21.24%
OCF growth 1Y70.46%
OCF growth 3Y21.07%
OCF growth 5Y20.91%
HAMILTON LANE INC-CLASS A / HLNE FAQ
Can you provide the ChartMill fundamental rating for HAMILTON LANE INC-CLASS A?
ChartMill assigns a fundamental rating of 7 / 10 to HLNE.
What is the valuation status for HLNE stock?
ChartMill assigns a valuation rating of 3 / 10 to HAMILTON LANE INC-CLASS A (HLNE). This can be considered as Overvalued.
Can you provide the profitability details for HAMILTON LANE INC-CLASS A?
HAMILTON LANE INC-CLASS A (HLNE) has a profitability rating of 8 / 10.
Can you provide the PE and PB ratios for HLNE stock?
The Price/Earnings (PE) ratio for HAMILTON LANE INC-CLASS A (HLNE) is 27.42 and the Price/Book (PB) ratio is 9.84.
How financially healthy is HAMILTON LANE INC-CLASS A?
The financial health rating of HAMILTON LANE INC-CLASS A (HLNE) is 7 / 10.